Janssen Vaccines & Prevention B.V.
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Johnson_&_Johnson
|
| gptkbp:acquisitionYear |
2011
|
| gptkbp:CEO |
gptkb:Hugo_Van_der_Kuylen
|
| gptkbp:country |
gptkb:Netherlands
|
| gptkbp:founded |
gptkb:Crucell
|
| gptkbp:foundedYear |
1993
|
| https://www.w3.org/2000/01/rdf-schema#label |
Janssen Vaccines & Prevention B.V.
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:location |
gptkb:Leiden,_Netherlands
|
| gptkbp:notableProduct |
gptkb:Janssen_COVID-19_vaccine
|
| gptkbp:parentCompany |
gptkb:Johnson_&_Johnson
gptkb:Janssen_Pharmaceuticals |
| gptkbp:product |
vaccines
biopharmaceuticals |
| gptkbp:researchInterest |
infectious diseases
vaccine development |
| gptkbp:subsidiary |
gptkb:Johnson_&_Johnson
gptkb:Janssen_Pharmaceuticals |
| gptkbp:website |
https://www.janssen.com/netherlands/
|
| gptkbp:bfsParent |
gptkb:NCT04601051
|
| gptkbp:bfsLayer |
7
|